Search


Current filters:


Clear current filters  or Add more filters

View Option



Results 1-10 of 49 (Search time: 0.006 seconds).

  Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review (Journal article)

  High levels of topoisomerase IIalpha protein expression in diffuse large B-cell lymphoma are associated with high proliferation, germinal center immunophenotype, and response to treatment (Journal article)

  Gastrointestinal, urologic and lung malignancies during pregnancy (Journal article)

  Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial (Journal article)

  Global profiling of EGFR gene mutation, amplification, regulation and tissue protein expression in unknown primary carcinomas: to target or not to target? (Journal article)

  Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapy (Journal article)

  Trabectedin-related rhabdomyolysis: an uncommon but fatal toxicity (Journal article)

  Chemotherapy for patients with two favourable subsets of unknown primary carcinoma: active, but how effective? (Journal article)

  Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (Journal article)

  Cancer, fertility and pregnancy: ESMO clinical recommendations for diagnosis, treatment and follow-up (Journal article)